Its pretty obvious to see that the naysayers on the other

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Its pretty obvious to see that the naysayers on the other board for BSSP are out in force.

Would you waste time bashing a stock if there was nothing in it for you?

Exactly. These naysayers know exactly what they are doing.

I'm still holding to my .0082 share price for BSSP.

REVE Technologies, Inc. (BSSP) Stock Research Links

BSSP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

IntelAgree Recognized for Advanced AI Solutions in CLM

Updated Category News Views 283

IntelAgree Recognized for Innovation in CLM IntelAgree, a leading player in contract lifecycle management (CLM) powered by artificial intelligence, has recently been honored as an 'Advanced Solution' in a distinguished analysis by The Hackett Group. This recognition solidifies IntelAgree’s reputation as a top platform in the business sector. Importance of The Hackett...

Continue Reading
Emergency Health Workers in South Dakota Unionize with Teamsters

Updated Category News Views 248

Emergency Health Professionals Unite with Teamsters Local 120 Recently, a remarkable development unfolded as a dedicated group of 15 paramedics, EMTs, and emergency health professionals came together to join Teamsters Local 120. This resolute decision signifies their commitment to securing better working conditions and fair compensation. The Journey Toward Unionization...

Continue Reading
MSI Showcases Innovative Cloud Solutions at CloudFest 2025

Updated Category News Views 324

MSI Unveils Future-Proof Cloud Solutions At CloudFest 2025, MSI, a leader in high-performance server solutions, introduced its innovative next-generation server platforms, including the ORv3 Servers, DC-MHS Servers, and NVIDIA MGX™ AI Servers. This significant event showcased MSI's commitment to enhancing cloud infrastructure with a focus on scalability, performance,...

Continue Reading
St. Cloud Capital Invests in Mobile Diagnostic Services Expansion

Updated Category News Views 110

St. Cloud Capital's Growth Capital Investment St. Cloud Capital has proudly announced a significant investment in Integrated Diagnostic Services (IDS). This initiative focuses on expanding their capabilities in mobile radiology and laboratory services. The investment aims to support IDS in acquiring Core Analytics Lab & Radiology, a leading provider in California....

Continue Reading
LeMaitre Vascular's Impressive Q3 2024 Performance Report

Updated Category News Views 83

LeMaitre Vascular Shows Robust Growth in Q3 2024 BURLINGTON, Mass. – LeMaitre Vascular, Inc. (NASDAQ: LMAT), a leading provider of vascular devices and services, has reported exceptional results for the third quarter of 2024. The company’s strong performance demonstrates its commitment to innovation in the medical device sector, especially in the area of vascular...

Continue Reading